Vertex Pharmaceuticals Inc. buy Bank of America Co. - sharewise

Dec 19, 2024 · This prediction is currently active. With a performance of 4.03%, the BUY prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc. is trending in the right …

03%
OFF

Vertex Pharmaceuticals Inc. Buy Bank Of America Co. - Sharewise

1 day from now

Dec 19, 2024 · This prediction is currently active. With a performance of 4.03%, the BUY prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc. is trending in the right …

sharewise.com

$397.27
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut To …

1 day from now

Dec 21, 2024 · Shares of Vertex Pharmaceuticals stock opened at $397.27 on Thursday. The company has a quick ratio of 2.20, a current ratio of 2.47 and a debt-to-equity ratio of 0.01. …

etfdailynews.com

$545.00
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut To …

1 day from now

Dec 22, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective lowered by Bank of America from $545.00 to $522.00 in a research report sent to investors on …

americanbankingnews.com

$397.27
OFF

Bank Of America Issues Pessimistic Forecast For Vertex …

1 day from now

Dec 21, 2024 · NASDAQ:VRTX opened at $397.27 on Thursday. Vertex Pharmaceuticals has a one year low of $377.85 and a one year high of $519.88. The business’s 50-day simple …

defenseworld.net

$242
OFF

Bank Of America Securities Stick To Their Buy Rating For Vertex ...

1 day from now

Nov 3, 2021 · The current consensus among 11 TipRanks analysts is for a Moderate Buy rating of shares in Vertex Pharmaceuticals, with an average price target of $242.5. The analysts price …

investing.com

$2
OFF

Vertex Pharmaceuticals Incorporated Shares Owned By Bank Of …

1 day from now

Quarter filed Position value Share count Share price at filing; 2012-12-31 $2.1M : 51k : 41.90 : 2012-09-30 $46M : 829k

stockzoa.com

710%
OFF

Should You Buy Vertex Pharmaceuticals On The Dip Before

1 day from now

Dec 22, 2024 · The price for the Vertex Pharmaceuticals Inc. stock decreased slightly today. Compared to yesterday there is a change of -€2.700 (-0.710%). With 59 Buy predictions and 2 …

sharewise.com

83%
OFF

Vertex Pharmaceuticals Inc. Buy JPMorgan Chase & Co. - Sharewise

1 day from now

5 days ago · This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 2.83%. This prediction currently runs until 23.12.25. The prediction end …

sharewise.com

56%
OFF

Vertex Pharmaceuticals Inc. Buy Truist Financial Co. - Sharewise

1 day from now

5 days ago · This prediction is currently active. With a performance of 2.56%, the BUY prediction by Truist_Financial_Co_ for Vertex Pharmaceuticals Inc. is trending in the right direction. This …

sharewise.com

49%
OFF

Vertex Pharmaceuticals Inc. Buy BMO Capital Markets - Sharewise

1 day from now

Dec 20, 2024 · Summary This prediction is currently active. With a performance of 2.49%, the BUY prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc. is trending in the …

sharewise.com

FAQs about Vertex Pharmaceuticals Inc. buy Bank of America Co. - sharewise Coupon?

Is Vertex Pharmaceuticals a good stock to buy?

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vertex Pharmaceuticals with a $377.26 average price target, which is a 7.07% upside from current levels. In a report released on July 28, Bernstein also maintained a Buy rating on the stock with a $380.00 price target. ...

Should you buy Vertex Pharmaceuticals (VRTX – research report)?

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s shares closed last Friday at $397.27. According to TipRanks, Ahmad is a 3-star analyst with an average return of 1.5% and a 48.03% success rate. ...

How did Vertex Pharmaceuticals perform compared to last year?

Based on Vertex Pharmaceuticals’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.77 billion and a net profit of $1.05 billion. In comparison, last year the company earned a revenue of $2.48 billion and had a net profit of $1.04 billion ...

Should Scotiabank hold Vertex Pharmaceuticals (VRTX)?

However, on the same day, Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (NASDAQ: VRTX). Based on Vertex Pharmaceuticals’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.77 billion and a net profit of $1.05 billion. ...